Control Bionics Limited (ASX:CBL)
0.0500
-0.0010 (-1.96%)
Nov 17, 2026, 11:12 AM AEDT
Control Bionics Market Cap
Control Bionics has a market cap or net worth of 27.15 million as of November 16, 2026. It is the 37,212th most valuable company in the world and the 957th biggest in Australia. Its market cap has increased by 21.92% in one year.
Market Cap
27.15M
Enterprise Value
25.62M
Revenue
4.77M
Global Rank
Country Rank
#957 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since December 7, 2020, Control Bionics's market cap has decreased from 98.33M to 27.15M, a decrease of -72.39%. That is a compound annual growth rate of -19.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 28.78M | 16.94% |
| Dec 31, 2025 | 24.61M | 62.80% |
| Dec 31, 2024 | 15.12M | 126.88% |
| Dec 29, 2023 | 6.66M | -55.36% |
| Dec 30, 2022 | 14.93M | -59.58% |
| Dec 30, 2021 | 36.94M | -52.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Epiminder | 59.58M |
| Cyclopharm | 57.84M |
| Saluda Medical | 50.40M |
| Compumedics | 48.94M |
| Nova Eye Medical | 45.59M |
| HeraMED | 40.55M |
| CleanSpace Holdings | 38.10M |
| Cleo Diagnostics | 37.02M |